IART

24.58

0.16% 0.04

Dopo l'orario di chiusura: 24.58

Integra Lifesciences Holdings Corp (IART)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Forum Previsione Frazionamento azionario

Precedente Chiudi:

$24.54

Aprire:

$24.59

Volume 24 ore:

235.48K

Relative Volume:

0.25

Capitalizzazione di mercato:

$1.90B

Reddito:

$1.53B

Utile/perdita netta:

$40.23M

Rapporto P/E:

20.31

EPS:

1.21

Flusso di cassa netto:

$60.93M

1 W Prestazione:

+4.24%

1M Prestazione:

+26.05%

6M Prestazione:

-16.96%

1 anno Prestazione:

-37.22%

Intervallo 1D:

$24.39

$24.87

Intervallo di 1 settimana:

$23.44

$24.87

Portata 52W:

$16.80

$45.42

Integra Lifesciences Holdings Corp Stock (IART) Company Profile

Nome

Integra Lifesciences Holdings Corp

Settore

Healthcare (1180)

Industria

Medical Devices (148)

Telefono

(609) 275-0500

Indirizzo

1100 CAMPUS ROAD, PRINCETON, NJ

Dipendente

3,946

Cinguettio

@integra_life

Prossima data di guadagno

2024-11-04

Ultimi documenti SEC

IART's Discussions on Twitter

Confronta IART con altri titoli

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IART Integra Lifesciences Holdings Corp	24.58	1.90B	1.53B	40.23M	60.93M	0.50
ABT Abbott Laboratories	118.77	206.00B	41.22B	5.77B	6.49B	3.29
SYK Stryker Corp	392.15	149.49B	21.97B	3.59B	3.21B	9.33
BSX Boston Scientific Corp	90.66	133.62B	15.91B	1.79B	1.89B	1.21
MDT Medtronic Plc	86.54	110.97B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	71.35	42.08B	6.60B	4.16B	490.10M	6.93

Integra Lifesciences Holdings Corp Stock (IART) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2024-10-07	Aggiornamento	BTIG Research	Sell → Neutral
2024-07-30	Downgrade	BTIG Research	Neutral → Sell
2024-07-30	Downgrade	Citigroup	Neutral → Sell
2024-05-07	Downgrade	Oppenheimer	Outperform → Perform
2024-05-07	Downgrade	Wells Fargo	Overweight → Equal Weight
2024-04-03	Aggiornamento	Citigroup	Sell → Neutral
2023-12-05	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-11-14	Iniziato	CL King	Buy
2023-08-24	Downgrade	Morgan Stanley	Equal-Weight → Underweight
2023-07-12	Aggiornamento	Jefferies	Hold → Buy
2023-06-08	Downgrade	Argus	Buy → Hold
2023-05-24	Downgrade	JP Morgan	Neutral → Underweight
2023-05-23	Downgrade	Citigroup	Neutral → Sell
2022-10-12	Iniziato	Jefferies	Hold
2022-07-25	Iniziato	Morgan Stanley	Equal-Weight
2022-04-13	Downgrade	Truist	Buy → Hold
2021-12-17	Aggiornamento	JP Morgan	Underweight → Neutral
2021-09-15	Downgrade	BTIG Research	Buy → Neutral
2020-10-08	Downgrade	JP Morgan	Neutral → Underweight
2020-05-27	Iniziato	Citigroup	Neutral
2020-04-03	Iniziato	SunTrust	Buy
2020-01-07	Downgrade	Piper Jaffray	Overweight → Neutral
2020-01-07	Downgrade	Piper Sandler	Overweight → Neutral
2019-01-03	Iniziato	SunTrust	Buy
2018-11-28	Iniziato	UBS	Neutral
2018-08-07	Downgrade	BofA/Merrill	Neutral → Underperform
2018-07-26	Aggiornamento	BTIG Research	Neutral → Buy
2018-07-02	Downgrade	Citigroup	Buy → Neutral
2018-01-05	Ripresa	Cantor Fitzgerald	Neutral
2018-01-02	Downgrade	BofA/Merrill	Buy → Neutral
2017-11-09	Reiterato	RBC Capital Mkts	Sector Perform
2017-10-30	Downgrade	Wells Fargo	Outperform → Market Perform
2017-10-27	Downgrade	JP Morgan	Overweight → Neutral
2017-06-30	Iniziato	Cantor Fitzgerald	Overweight
2017-05-02	Reiterato	RBC Capital Mkts	Sector Perform
2017-01-13	Reiterato	RBC Capital Mkts	Sector Perform
2017-01-06	Aggiornamento	JMP Securities	Mkt Perform → Mkt Outperform
2016-12-12	Iniziato	UBS	Buy

Mostra tutto

Integra Lifesciences Holdings Corp Borsa (IART) Ultime notizie

Nov 30, 2024

Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Victory Capital Management Inc. - Defense World

Nov 30, 2024

Nov 26, 2024

Chronic Wound Care Market to Expand at a Modest 4.17% CAGR through 2031 | SkyQuest Technology - Benzinga

Nov 26, 2024

Nov 16, 2024

Regenerative Medicine Market to grow by USD 70.11 Billion (2024-2028), rising prevalence of chronic diseases to drive revenue, Report with AI-powered insightsTechnavio - The Malaysian Reserve

Nov 16, 2024

Nov 13, 2024

Integra Lifesciences (IART) Stock Dips Amid Financial Concerns - GuruFocus.com

Nov 13, 2024

Integra’s DuraSeal® Dural Sealant Saves Healthcare Costs According to an Economic Evaluation Published in the Journal of Comparative Effectiveness Research - Yahoo Finance

Nov 13, 2024

Fuller & Thaler Asset Management, Inc. Expands Stake in Integra Lifesciences Holdings Corp - GuruFocus.com

Nov 13, 2024

Capital Research Global Investors Reduces Stake in Integra Lifes - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

Integra LifeSciences Holdings Co. (NASDAQ:IART) Given Consensus Rating of "Reduce" by Analysts - MarketBeat

Nov 12, 2024

Nov 11, 2024

Integra LifeSciences : Serving Those Who Served - Marketscreener.com

Nov 11, 2024

Nov 09, 2024

Easterly Investment Partners LLC Has $1.12 Million Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat

Nov 09, 2024

Nov 08, 2024

Leeward Investments LLC MA Has $6.83 Million Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat

Nov 08, 2024

Nov 07, 2024

Integra Lifesciences (IART) Stock Sees Sharp 5.09% Decline Amid Market Fluctuations - GuruFocus.com

Nov 07, 2024

Olstein Capital Management L.P. Has $2.82 Million Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART) - MarketBeat

Nov 07, 2024

Wound Dressing Market: Size, Share, Trends, and Global Analysis - openPR

Nov 07, 2024

Nov 06, 2024

Integra LifeSciences price target raised to $22 from $16 at Citi - Yahoo Finance

Nov 06, 2024

Louisiana State Employees Retirement System Sells 2,200 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART) - Defense World

Nov 06, 2024

Nov 05, 2024

IART (Integra Lifesciences Holdings) PE Ratio without NRI : 8.77 (As of Nov. 05, 2024) - GuruFocus.com

Nov 05, 2024

Integra Q3 Earnings, Revenues Beat, Stock Up Despite Margin Pressure - MSN

Nov 05, 2024

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Q3 2024 Earnings Call Transcript - Insider Monkey

Nov 05, 2024

Integra LifeSciences Holdings Third Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance

Nov 05, 2024